Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Q4 2025 Earnings Call Transcript February 11, 2026
Neurocrine Biosciences, Inc. misses on earnings expectations. Reported EPS is $1.5 EPS, expectations were $2.25.
Operator: Hello, and welcome, everyone, joining today’s Neurocrine Biosciences Fourth Quarter and Fiscal Year 2025 Earnings Call. [Operator Instructions] Please note, this call is being recorded. [Operator Instructions] And it is now my pleasure to turn the meeting over to Todd Tushla,...
